Organoclick AB Capital Reinvestment Ratio
Organoclick AB capital reinvestment ratio. Organoclick AB (ORGC) has a Capital Reinvestment Ratio of 0.11x as of June 2026, meaning it reinvests 0% of its operating cash flow (Skr1.91 Million) in capital expenditures (Skr210.00K). Check Organoclick AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Organoclick AB (2013–2024)
Capital reinvestment ratio of Organoclick AB from 2013 to 2024. This chart tracks Organoclick AB's Capital Reinvestment Ratio across 4 annual periods. Also explore ORGC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Organoclick AB Capital Reinvestment Ratio by Year (2013–2024)
Organoclick AB capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see Organoclick AB operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.53x | Skr3.60 Million | Skr9.11 Million | ▼ -84.3% |
| 2023 | 16.15x | Skr533.00K | Skr8.61 Million | ▲ +355.6% |
| 2020 | 3.55x | Skr5.47 Million | Skr19.40 Million | ▲ +1.4% |
| 2013 | 3.50x | Skr313.54K | Skr1.10 Million | — |